These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20349488)

  • 21. Reaction of N-monosubstituted hydrazones with nitroolefins: a novel regioselective pyrazole synthesis.
    Deng X; Mani NS
    Org Lett; 2006 Aug; 8(16):3505-8. PubMed ID: 16869646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazolo[3,4-d]pyrimidinophanes: convenient synthesis of a new class of cyclophane and X-ray structure of the first representative.
    Avasthi K; Ansari A; Tewari AK; Kant R; Maulik PR
    Org Lett; 2009 Nov; 11(22):5290-3. PubMed ID: 19905030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
    J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation of 1-(2-nitrovinyl)-pyrazole derivatives].
    French J; Peseke K; Kristen H; Bräuniger H
    Pharmazie; 1976; 31(12):851-5. PubMed ID: 1023261
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of inhibitors of protein kinase B using fragment-based lead discovery.
    Saxty G; Woodhead SJ; Berdini V; Davies TG; Verdonk ML; Wyatt PG; Boyle RG; Barford D; Downham R; Garrett MD; Carr RA
    J Med Chem; 2007 May; 50(10):2293-6. PubMed ID: 17451234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors.
    Aronov AM; Baker C; Bemis GW; Cao J; Chen G; Ford PJ; Germann UA; Green J; Hale MR; Jacobs M; Janetka JW; Maltais F; Martinez-Botella G; Namchuk MN; Straub J; Tang Q; Xie X
    J Med Chem; 2007 Mar; 50(6):1280-7. PubMed ID: 17300186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of pyrazoles in the solid state: a combined CPMAS, NMR, and crystallographic study.
    Claramunt RM; Cornago P; Torres V; Pinilla E; Torres MR; Samat A; Lokshin V; Valés M; Elguero J
    J Org Chem; 2006 Sep; 71(18):6881-91. PubMed ID: 16930041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors.
    Zhang X; Song F; Kuo GH; Xiang A; Gibbs AC; Abad MC; Sun W; Kuo LC; Sui Z
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4762-7. PubMed ID: 21767952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa.
    Smallheer JM; Alexander RS; Wang J; Wang S; Nakajima S; Rossi KA; Smallwood A; Barbera F; Burdick D; Luettgen JM; Knabb RM; Wexler RR; Jadhav PK
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5263-7. PubMed ID: 15454208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four substituted pyrazolines.
    Chopra D; Mohan TP; Vishalakshi B; Row TN
    Acta Crystallogr C; 2007 Dec; 63(Pt 12):o746-50. PubMed ID: 18057630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of withasomnines and their non-natural analogues from aldehydes and 4-nitro-1-butanol in three steps.
    Verma D; Kumar R; Namboothiri IN
    J Org Chem; 2013 Apr; 78(7):3482-6. PubMed ID: 23438044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrazole complexes as anion receptors: effects of changing the metal, the pyrazole substitution pattern, and the number of pyrazole ligands.
    Nieto S; Pérez J; Riera L; Riera V; Miguel D; Golen JA; Rheingold AL
    Inorg Chem; 2007 Apr; 46(8):3407-18. PubMed ID: 17367132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
    Lee SH; Seo HJ; Lee SH; Jung ME; Park JH; Park HJ; Yoo J; Yun H; Na J; Kang SY; Song KS; Kim MA; Chang CH; Kim J; Lee J
    J Med Chem; 2008 Nov; 51(22):7216-33. PubMed ID: 18954042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An effective and general method for the highly regioselective synthesis of 1-phenylpyrazoles from beta-enaminoketoesters, tandem Blaise-acylation adducts.
    Ko YO; Chun YS; Park CL; Kim Y; Shin H; Ahn S; Hong J; Lee SG
    Org Biomol Chem; 2009 Mar; 7(6):1132-6. PubMed ID: 19262932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.
    Dressen D; Garofalo AW; Hawkinson J; Hom D; Jagodzinski J; Marugg JL; Neitzel ML; Pleiss MA; Szoke B; Tung JS; Wone DW; Wu J; Zhang H
    J Med Chem; 2007 Oct; 50(21):5161-7. PubMed ID: 17880055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.
    Ledeboer MW; Pierce AC; Duffy JP; Gao H; Messersmith D; Salituro FG; Nanthakumar S; Come J; Zuccola HJ; Swenson L; Shlyakter D; Mahajan S; Hoock T; Fan B; Tsai WJ; Kolaczkowski E; Carrier S; Hogan JK; Zessis R; Pazhanisamy S; Bennani YL
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6529-33. PubMed ID: 19857967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of novel nitro-substituted triaryl pyrazole derivatives as potential estrogen receptor ligands.
    Naoum F; Kasiotis KM; Magiatis P; Haroutounian SA
    Molecules; 2007 Jul; 12(7):1259-73. PubMed ID: 17909483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and anti-microbial activity of 1H-pyrazole carboxylates.
    Sridhar R; Perumal PT; Etti S; Shanmugam G; Ponnuswamy MN; Prabavathy VR; Mathivanan N
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6035-40. PubMed ID: 15546724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
    Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
    Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships.
    Camacho ME; León J; Entrena A; Velasco G; Carrión MD; Escames G; Vivó A; Acuña-Castroviejo D; Gallo MA; Espinosa A
    J Med Chem; 2004 Nov; 47(23):5641-50. PubMed ID: 15509163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.